News

Practice Memo urges partnership between surgeons and podiatrists


 

References

Many dollars and feet can be saved when podiatrists and vascular surgeons work together for patients with diabetic foot ulcerations (DFUs).

Effective partnerships between these two specialties can address one of the most challenging health care populations in the United States, according to a new practice memo, “Building Effective Partnerships Between Vascular Surgeons and Podiatrists in the Effective Management of Diabetic Foot Ulcers.”

Courtesy of SVS

The practice memo, a collaborative effort between the Young Physicians Programs of the American Podiatric Medical Association and the Young Surgeons Committee of the SVS, aims to aid podiatrists and vascular surgeons who are early in their careers with the establishment of strong interprofessional partnerships.

As the prevalence of DFUs has increased, so have the associated costs of care. Peripheral vascular complications of diabetes accounted for 31% of the cost of treating diabetes in an estimated 24 million Americans in 2007, which amounted to a total of $174 billion, according to the memo. A Medicare analysis in in the mid-’90s found that expenditures for diabetic foot patients were three times higher than for the general population. The memo is posted on the SVS website at vsweb.org/DFU.

Recommended Reading

Eruptive xanthoma
Type 2 Diabetes ICYMI
What to do after basal insulin: 3 Tx strategies for type 2 diabetes
Type 2 Diabetes ICYMI
Do statins increase the risk of developing diabetes?
Type 2 Diabetes ICYMI
Glyburide in pregnancy linked to respiratory distress, NICU admission
Type 2 Diabetes ICYMI
Metformin shows superior glycemic durability
Type 2 Diabetes ICYMI
Lowering dietary fat, not carbs, led to greater body fat loss
Type 2 Diabetes ICYMI
Poor control of CVD risk factors raises morbidity, mortality risk in diabetes
Type 2 Diabetes ICYMI
The ‘connected’ health care consumer
Type 2 Diabetes ICYMI
Metformin Shows Superior Glycemic Durability
Type 2 Diabetes ICYMI
Predictors of Suboptimal Glycemic Control for Hospitalized Patients with Diabetes: Targets for Clinical Action
Type 2 Diabetes ICYMI